$NSP

INSPERITY, INC.

No enriched coverage for $NSP in the last 7 days.

No SEC Form 4 filings for $NSP in the last 30 days.

Med

JPMorgan Chase & Co. Lowers Insperity (NYSE:NSP) Price Target to $33.00

JPMorgan Chase & Co. has lowered its price target for Insperity (NYSE:NSP) from $35.00 to $33.00, maintaining an "underweight" rating, which still implies a 13.75% potential upside. This adjustment comes after Insperity's stock plunged 18.4% to $29.01 due to weakened worksite employee volume and negative profitability metrics, despite insider buying from CEO Paul J. Sarvadi. The company also announced lowered guidance for Q2 and the full fiscal year 2026.

Insperity (NYSE:NSP) Updates Q2 2026 Earnings Guidance

Insperity (NYSE:NSP) has updated its Q2 2026 earnings per share guidance to $0.020-$0.500, with full-year 2026 EPS guidance set at $1.600-$2.600. The company recently beat Q1 estimates with $1.31 EPS and $1.90 billion in revenue. Despite a negative P/E ratio and net margin, insiders have shown recent buying activity, and the company offers a quarterly dividend with a 6.8% yield.

Insperity sees 2026 adjusted EPS at $1.60-$2.60 as WSEEs dip

Insperity (NYSE: NSP) reported its first-quarter 2026 financial results, with revenues up 2% to $1.9 billion and diluted EPS at $0.88. The company's average paid worksite employees (WSEEs) decreased by 1% year-over-year. Insperity provided guidance for fiscal year 2026, forecasting adjusted EPS between $1.60 and $2.60 and adjusted EBITDA between $170 million and $230 million, despite an expected decrease in WSEEs.